Kristin Skougaard

Impact of CYP2C8*3 on paclitaxel clearance: a population pharmacokinetic and pharmacogenomic study in 93 patients with ovarian cancer

Troels K. Bergmann, Charlotte Brasch‐Andersen, Henrik Gréen et al. · The Pharmacogenomics Journal · 2010 · 95 citations · Full text

Population Pharmacokinetic, Oncology, Medicine +6

Comparison of EORTC Criteria and PERCIST for PET/CT Response Evaluation of Patients with Metastatic Colorectal Cancer Treated with Irinotecan and Cetuximab

Kristin Skougaard, Dorte Nielsen, Benny Vittrup Jensen et al. · Journal of Nuclear Medicine · 2013 · 82 citations · Full text

Impact of<i>ABCB1</i>Variants on Neutrophil Depression: A Pharmacogenomic Study of Paclitaxel in 92 Women with Ovarian Cancer

Troels K. Bergmann, Charlotte Brasch‐Andersen, Henrik Gréen et al. · Basic & Clinical Pharmacology & Toxicology · 2011 · 40 citations

Dual time point imaging fluorine-18 flourodeoxyglucose positron emission tomography for evaluation of large loco-regional recurrences of breast cancer treated with electrochemotherapy

Louise Wichmann Matthiessen, Helle Hjorth Johannesen, Kristin Skougaard et al. · Radiology and Oncology · 2013 · 22 citations · Full text

CT versus FDG‐PET/CT response evaluation in patients with metastatic colorectal cancer treated with irinotecan and cetuximab

Kristin Skougaard, Helle Hjorth Johannesen, Dorte Nielsen et al. · Cancer Medicine · 2014 · 20 citations · Full text

Surgical Oncology, Oncologic Imaging, Pathology +17